Overview

Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

This purpose of this study is to determine if the herbal compound, Blue Citrus, decreases joint and bone pain associated with Aromotase Inhibitor therapy (AIT). Another purpose of the study is to find out if Blue Citrus improves how you feel while taking AIT and if your quality of life improves.

Phase:

N/A

Details

Lead Sponsor:

Legacy Health System

Treatments:

Aromatase Inhibitors